483
Cipla Ltd.Cipla Ltd. – FDA 483, May 26, 2025
Record Details
Cipla Ltd., an API manufacturer in Bangalore, India, was cited for inadequate cGMP controls during an FDA inspection. The firm failed to extend investigations into related deviations, lab incidents, and other quality events, leading to a lack of trending for recurring issues. Additionally, the inspection noted numerous failed batches and concerns regarding the accuracy and reproducibility of QC laboratory test methods.
View Company Profile
ID · 1e5d4e6e-c770-4dc1-bfc6-14c2d583e30c
Other documents for Cipla Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.